This provided a novel mechanism by which melanoma cells could remodel the ECM in TME, thus targeting MT1-MMP in EVs, or depressing the release of tumor cell derived EVs might be a promising strategy for melanoma treatment. This evidence concerns the gene MMP14 and melanoma.